1023 / 1851
Hybrid study:
SBRT with concurrent chemoradiation
Treatment planning and delivery
2 isocentres and 2 dual VMAT arcs
Compensation for indirect lymph node (LN)
dose to primary tumour (PT): the biological
equivalent of the minimal dose (D99) to the PT
PTV from LN irradiation was subtracted from
the biological prescribed dose to the PTV.
Chemotherapy consisted of daily low dose
Cisplatinum 6 mg/m
2
PT: 3 x 18 Gy (purple)
LN: 24 x 2.42 Gy (pink)
Courtesy of J. Belderbos